
    
      The specific aims include:

      Primary Aims:

        1. Examine the efficacy of telmisartan added to regular doses of clozapine or olanzapine in
           improving insulin resistance.

        2. Examine the efficacy of telmisartan in reducing fasting triglycerides.

      Secondary Aims:

        1. Examine the effects of telmisartan on negative symptoms, positive symptoms, and
           cognitive function.

        2. Examine telmisartan's effects on lipids, body composition, and waist/hip ratio.

        3. Examine telmisartan's effects on inflammatory biomarkers including C-reactive protein
           (CRP) and interleukin 6 (IL-6).
    
  